The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Open accessAbstract
Cardiovascular disease is the leading cause of mortality in uremic patients. In large cross-sectional studies of dialysis patients, traditional cardiovascular risk factors such as hypertension and hypercholesterolemia have been found to have low predictive power, while markers of inflammation and malnutrition are highly correlated with cardiovascular mortality. However, the pathophysiology of the disease process that links uremia, inflammation, and malnutrition with increased cardiovascular complications is not well understood. We hereby propose the hypothesis that increased oxidative stress and its sequalae is a major contributor to increased atherosclerosis and cardiovascular morbidity and mortality found in uremia. This hypothesis is based on studies that conclusively demonstrate an increased oxidative burden in uremic patients, before and particularly after renal replacement therapies, as evidenced by higher concentrations of multiple biomarkers of oxidative stress. This hypothesis also provides a framework to explain the link that activated phagocytes provide between oxidative stress and inflammation (from infectious and non-infections causes) and the synergistic role that malnutrition (as reflected by low concentrations of albumin and/or antioxidants) contributes to the increased burden of cardiovascular disease in uremia. We further propose that retained uremic solutes such as beta-2 microglobulin, advanced glycosylated end products (AGE), cysteine, and homocysteine, which are substrates for oxidative injury, further contribute to the pro-atherogenic milieu of uremia. Dialytic therapy, which acts to reduce the concentration of oxidized substrates, improves the redox balance. However, processes related to dialytic therapy, such as the prolonged use of catheters for vascular access and the use of bioincompatible dialysis membranes, can contribute to a pro-inflammatory and pro-oxidative state and thus to a pro-atherogenic state. Anti-oxidative therapeutic strategies for patients with uremia are in their very early stages; nonetheless, early studies demonstrate the potential for significant efficacy in reducing cardiovascular complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The uncoupling of endothelial nitric oxide synthase (eNOS), oxidative stress mechanism is involved in uremia, a condition when the kidney does not work properly and waste products instead of urine are excreted into the bloodstream (Himmelfarb et al. 2002).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Himmelfarb et al. 2002
Citations
Cites
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
Clinical epidemiology of cardiovascular disease in chronic renal disease
Rn, F., Parfrey, P. S., & Sarnak, M. J. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,960
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Dietary Protein Intake and the Progressive Nature of Kidney Disease:
Epstein, F. H., Brenner, B. M., Meyer, T. W., & Hostetter, T. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209093071104 · Cited by 2,067
Advanced oxidation protein products as a novel marker of oxidative stress in uremia
Witko‐Sarsat, V., Friedlander, M. A., Capeillère‐Blandin, C., Nguyen‐Khoa, T., Nguyen, A., Zingraff, J., Jungers, P., & Descamps‐Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 2,000
Lowrie, E. G., & Lew, N. L. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70364-5 · Cited by 1,965
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
Stenvinkel, P., Heimbürger, O., Paultre, F., Diczfalusy, U., Wang, T., Berglund, L., & Jogestrand, T. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00422.x · Cited by 1,767
Self-citation
Research works printed but not linked: 1
- Bloembergen, 1995, The relationship of dialysis membrane and cause-specific mortality in chronic hemodialysis patients, J Am Soc Nephrol, 6, 521
Cited by
Sorted by citations
Items 701–800 of 1,000
Colombo, G., Reggiani, F., Astori, E., Altomare, A., Finazzi, S., Garavaglia, M. L., Angelini, C., Milzani, A., Badalamenti, S., & Dalle‐Donne, I. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1690651 · Cited by 15
Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients
Ikizler, T. A. (2004) · Advances in Chronic Kidney Disease · doi:10.1053/j.arrt.2004.01.008 · Cited by 15
Self-citationAre biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
Rubin, C., Nolin, T. D., & Himmelfarb, J. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f0b331 · Cited by 15
Self-citationNew Approaches for the Treatment of Genomic Damage in End-Stage Renal Disease
Schupp, N., Schmid, U., Heidland, A., & Stopper, H. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.10.026 · Cited by 15
Variability of oxidative stress biomarkers in hemodialysis patients
Dahwa, R., Fassett, R. G., Wang, Z., Briskey, D. R., Mallard, A. R., & Coombes, J. S. (2014) · Biomarkers · doi:10.3109/1354750x.2013.867533 · Cited by 14
Nakayama, M., Kabayama, S., & Miyazaki, M. (2024) · Antioxidants · doi:10.3390/antiox13010090 · Cited by 14
Freburger, J. K., Ellis, A. R., Kshirsagar, A. V., Wang, L., & Brookhart, M. A. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-154 · Cited by 14
Glycemic load is associated with oxidative stress among prevalent maintenance hemodialysis patients
Limkunakul, C., Sundell, M. B., Pouliot, B., Graves, A. J., Shintani, A., & Ikizler, T. A. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft489 · Cited by 14
Self-citationArteriovenous Fistula Failure: Is There a Role for Epigenetic Regulation?
Campos, B., Lee, T. C., & Roy‐Chaudhury, P. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.05.012 · Cited by 14
van der Giet, M., Tölle, M., Praticò, D., Lufft, V., Schuchardt, M., Hörl, M. P., Zidek, W., & Tietge, U. J. F. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0543-3 · Cited by 14
A review of risk factors for stroke in patients with chronic kidney disease.
Saeed, F., Kousar, N., Qureshi, K., & Laurence, T. N. (2009) · PubMed Central · Cited by 14
Parathyroid hormone results interpretation in the background of variable analytical performance
Cavalier, E. (2019) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm.2018.12.03 · Cited by 14
Zhang, H., Fan, L., Liao, H., Tu, L., Zhang, J., Xu, D., & Feng, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9681 · Cited by 14
Are Nutraceuticals Beneficial in Chronic Kidney Disease?
Rysz, J., Franczyk, B., Kujawski, K., Sacewicz‐Hofman, I., Ciałkowska-Rysz, A. D., & Gluba-Brzózka, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020231 · Cited by 14
Garbowski, M., Cabantchik, I. Z., Hershko, C., Hider, R. C., & Porter, J. B. (2022) · American Journal of Hematology · doi:10.1002/ajh.26819 · Cited by 14
Manzano-Lista, F. J., Sanz‐Gómez, M., González‐Moreno, D., Vega-Martín, E., Gil‐Ortega, M., Schulz, A. M., Rubio, M. Á., Ruiz‐Hurtado, G., Ruilope, L. M., Aránguez, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010040 · Cited by 14
Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease
Ameer, O. Z., Boyd, R. A., Butlin, M., Avolio, A. P., & Phillips, J. K. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00150 · Cited by 16
Kitabayashi, C., Naruko, T., Sugioka, K., Yunoki, K., Nakagawa, M., Inaba, M., Ohsawa, M., Konishi, Y., Imanishi, M., Inoue, T., et al. (2013) · Hemodialysis International · doi:10.1111/hdi.12049 · Cited by 14
Moradi, H., Said, H. M., & Vaziri, N. D. (2012) · Translational research · doi:10.1016/j.trsl.2012.11.001 · Cited by 14
Ghrelin and Muscle Metabolism in Chronic Uremia
Barazzoni, R., Cappellari, G. G., Zanetti, M., & Guarnieri, G. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2011.10.017 · Cited by 14
Is Early Initiation of Dialysis Harmful?
Rivara, M. B., & Mehrotra, R. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12218 · Cited by 14
Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit?
Assimon, M. M., Salenger, P. V., El‐Fawal, H. A. N., & Mason, D. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01555.x · Cited by 14
The hydrogen molecule as antioxidant therapy: clinical application in hemodialysis and perspectives
Nakayama, M., Kabayama, S., & Ito, S. (2016) · Renal Replacement Therapy · doi:10.1186/s41100-016-0036-0 · Cited by 14
Hsieh, Y., Kuo, J.-F., Su, S., Chen, J., Chen, H., & Hsieh, M. (2016) · Medicine · doi:10.1097/md.0000000000002200 · Cited by 14
Mao, Y.-H., Xu, L.-N., Weng, Q., Li, X.-Y., Zhao, B., Nie, J.-J., Hu, J.-H., Zhang, L., Chen, Z., Zuo, M.-Z., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4237812 · Cited by 14
Tariq, A., Mansoor, M. A., Marti, H., Jonsson, G., Slettan, A., Weeraman, P., & Apeland, T. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.04.010 · Cited by 14
Effect of Hemodialysis on Plasma Myeloperoxidase Activity in End Stage Renal Disease Patients
Rao, A. M., Apoorva, R., Anand, U., Anand, C. V., & Venu, G. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0194-y · Cited by 14
Effect of Exercise Training on Aortic Tone in Chronic Renal Insufficiency
Shelkovnikov, S., Summers, S. M., Elahimehr, R., Adams, G. R., Purdy, R. E., & Vaziri, N. D. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.24 · Cited by 14
Effect of dialysis modality on plasma fibrinogen concentration: A meta-analysis
Goldwasser, P., Feldman, J. G., Emiru, M., & Barth, R. H. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.08.019 · Cited by 14
Cao, Y., Zhou, Y., Zhong, Y., Liao, X., Chen, X., & Pi, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1374719 · Cited by 13
Non-Invasive Diagnostic Approaches for Kidney Disease: The Role of Electronic Nose Systems
Sansone, F., & Tonacci, A. (2024) · Sensors · doi:10.3390/s24196475 · Cited by 14
Mechanisms underlying atrial fibrillation in chronic kidney disease
Navarro‐García, J. A., Keefe, J. A., Song, J., Li, N., & Wehrens, X. H. T. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.06.002 · Cited by 14
Macunluoğlu, B., Atakan, A., Arı, E., Kaya, Y., Kaspar, Ç., Demir, H., & Hakan, H. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.05.057 · Cited by 14
Rolla, R., Mauri, A. D., Valsesia, A., Vidali, M., Chiarinotti, D., & Bellomo, G. (2015) · Journal of Nephrology · doi:10.1007/s40620-015-0194-0 · Cited by 13
Chen, J., Lin, T., Liou, C., Liao, S., Lee, L.-C., Wang, P., & Tiao, M. (2008) · American Journal of Nephrology · doi:10.1159/000139638 · Cited by 13
Kamijo, Y., Wang, L., Matsumoto, A., Nakajima, T., Hashimoto, K., Higuchi, M., Kyogashima, M., Aoyama, T., & Hara, A. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0634-2 · Cited by 13
Sinha‐Hikim, I., Shen, R., Kovacheva, E. L., Crum, A., Vaziri, N. D., & Norris, K. C. (2010) · Cell Biology International · doi:10.1042/cbi20090349 · Cited by 13
Association of sequence polymorphism in the mitochondrial D-loop with chronic kidney disease
Bai, Y., Guo, Z., Xu, J., Zhang, J., Cui, L., Zhang, H., Zhang, S., & Ai, X. (2014) · Renal Failure · doi:10.3109/0886022x.2014.890842 · Cited by 13
Horoz, M., Bölükbaş, C., Bölükbaş, F. F., Koçyiğit, A., Aslan, M., Köylü, A. Ö., Gumus, M., Çelık, H., & Köksal, M. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.12.009 · Cited by 13
Matsumoto, Y., Mukai, M., Arihara, K., Saito, T., & Kumagai, H. (2011) · Renal Failure · doi:10.3109/0886022x.2011.568134 · Cited by 13
Testa, A., Leonardis, D., Spoto, B., Sanguedolce, M. C., Parlongo, R. M., Pisano, A., Tripepi, G., Mallamaci, F., & Zoccali, C. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000878 · Cited by 13
ApoB and apoM – New aspects of lipoprotein biology in uremia-induced atherosclerosis
Christoffersen, C., Bartels, E. D., Aarup, A., Nielsen, L. B., & Pedersen, T. X. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.053 · Cited by 13
Terawaki, H., Murase, T., Nakajima, A., Aoyagi, K., Fukushima, N., Tani, Y., Nakamura, T., & Kazama, J. J. (2017) · Journal of Clinical & Experimental Nephrology · doi:10.21767/2472-5056.100031 · Cited by 13
Hirakawa, Y., Jao, T., & Inagi, R. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12777 · Cited by 13
Monteiro, E. B., Soares, E. D. R., Trindade, P., de Bem, G. F., Resende, Â. C., Passos, M. M. C. D. F., Soulage, C. O., & Daleprane, J. B. (2019) · Experimental Physiology · doi:10.1113/ep088080 · Cited by 13
Pawlak, K., Pawlak, D., & Myśliwiec, M. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3281a3bee9 · Cited by 12
Oxidants and Iron in Progressive Kidney Disease
Shah, S. V. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.009 · Cited by 13
Kim, H. J., Yuan, J. J., Norris, K. C., & Vaziri, N. D. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.08.006 · Cited by 13
Himmelfarb, J. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10911105 · Cited by 13
Self-citationVitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions
Odetti, P. R., Traverso, N., Monacelli, F., Menini, S., Vazzana, J., Tasso, B., Pronzato, M. A., Robaudo, C., & Deferrari, G. (2005) · Free Radical Research · doi:10.1080/10715760500445121 · Cited by 13
Böger, C. A., Götz, A., Krüger, B., Hösl, M., Schmitz, G., Riegger, G. A. J., & Krämer, B. K. (2005) · PubMed · Cited by 13
Meyer, T. W., & Hostetter, T. H. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10053-3 · Cited by 13
Stites, W., & Froude, J. W. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.009 · Cited by 15
Hashemi, L., Hsiung, J.-T., Arif, Y., Soohoo, M., Jackson, N., Gosmanova, E. O., Budoff, M., Kovesdy, C., Kalantar-Zadeh, K., & Streja, E. (2022) · American Journal of Cardiology · doi:10.1016/j.amjcard.2022.01.034 · Cited by 9
Redox Signaling in Chronic Kidney Disease-Associated Cachexia
Silva, A. C. S. E., OLIVEIRA, E. A., Cheung, W. W., & MAK, R. H. K. (2023) · Antioxidants · doi:10.3390/antiox12040945 · Cited by 12
Lieb, W., Benndorf, R. A., Benjamin, E. J., SULLIVAN, L. M., Maas, R., Xanthakis, V., Schwedhelm, E., Aragam, J. R., Schulze, F., Böger, R. H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.018 · Cited by 12
Lin, T., Chiang, J., Liao, M., Tsai, C., Hwang, J., Chiang, F., Lin, J.-L., & Lin, L. (2015) · Scientific Reports · doi:10.1038/srep17731 · Cited by 12
Could Low-Protein Diet Modulate Nrf2 Pathway in Chronic Kidney Disease?
dos Anjos, J. S., Cardozo, L., Esgalhado, M., Lindholm, B., Stenvinkel, P., Fouque, D. P., & Mafra, D. (2018) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2017.11.005 · Cited by 12
Self-citationDimitrijević, Z., Šalinger-Martinović, S., Nikolic, V. N., & Cvetković, T. (2019) · Diagnostics · doi:10.3390/diagnostics9040202 · Cited by 13
Briet, M. B., Maruani, G., Collin, C., Bozec, E., Gauci, C., Boutouyrie, P., Houillier, P., Laurent, S., & Froissart, M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp373 · Cited by 12
Atherosclerosis and vascular calcification in uraemia - a new experimental model.
Ivanovski, O., Nikolov, I. G., Drueke, B. T., & Massy, A. Z. (2007) · PubMed · Cited by 12
Tagaya, M., Nagoshi, S., Matsuda, M., Takahashi, S., Okano, S., & Hara, K. (2017) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000631 · Cited by 12
Impact of uremia on human adipose tissue phenotype
Ho, K. J., Xue, H., Mauro, C. R., Nguyen, B., Yu, P., Tao, M., Seidman, M. A., Brunelli, S. M., & Ozaki, C. K. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.08.043 · Cited by 12
Nolin, T. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.003 · Cited by 12
Oxidative stress after uninephrectomy alters heart morphology in the apolipoprotein E −/− mouse
Piecha, G., Koleganova, N., Gross, M., Geldyyev, A., & Ritz, E. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830ef5e4 · Cited by 12
Lee, P.-W., Chien, C.-C., Yang, W.-C., Wang, J.-J., & Lin, C. (2012) · Journal of Nephrology · doi:10.5301/jn.5000224 · Cited by 12
Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients
Tiranathanagul, K., Eiam‐Ong, S., Tosukhowong, P., Praditpornsilpa, K., & Tungsanga, K. (2004) · Nephrology · doi:10.1111/j.1440-1797.2004.00262.x · Cited by 12
Xu, J., Guo, Z., Bai, Y., Zhang, J., Cui, L., Zhang, H., Zhang, S., & Ai, X. (2014) · Renal Failure · doi:10.3109/0886022x.2014.976132 · Cited by 12
Arteriovenous fistulas and digital hypoperfusion ischemic syndrome in patients on hemodialysis
Stolic, R. V. (2013) · World Journal of Nephrology · doi:10.5527/wjn.v2.i2.26 · Cited by 12
Bio-Incompatibility and Th2 Polarization during Regular Dialysis Treatment
Libetta, C., Sepe, V., & Canton, A. D. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.522282 · Cited by 12
El‐Habibi, E. M. (2013) · Cited by 11
Kato, S., Shiels, P. G., McGuinness, D., Lindholm, B., Stenvinkel, P., Nordfors, L., Qureshi, A. R., Yuzawa, Y., Matsuo, S., & Maruyama, S. (2015) · Blood Purification · doi:10.1159/000440971 · Cited by 12
Self-citationComplications of Chronic Kidney Disease
Legg, V. (2005) · AJN American Journal of Nursing · doi:10.1097/00000446-200506000-00024 · Cited by 12
Sabry, A. A.-A., El‐Shafey, E. M., Alsaran, K. A., Shalaby, M., Sherbeiny, S. A., & Morad, M. A. (2014) · Hemodialysis International · doi:10.1111/hdi.12145 · Cited by 11
Hung, T., Hsieh, Y., Lee, H., Ting, Y.-H., Lin, C., & Chao, W. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112314 · Cited by 11
Joun, J. H., Li, L., An, J. N., Jang, J., Oh, Y. K., Lim, C. S., Kim, Y. S., Choi, K., Lee, J. P., & Lee, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306025 · Cited by 11
Effect of vitamin D supplementation on endothelial dysfunction in hemodialysis patients
Karakaş, Y., Şahin, G., Urfalı, F. E., Bal, C., Akçar, N., & Sırmagül, B. (2016) · Hemodialysis International · doi:10.1111/hdi.12439 · Cited by 11
Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD
Hocher, B., & Pasch, A. (2017) · Kidney Diseases · doi:10.1159/000477244 · Cited by 11
Current epigenetic aspects the clinical kidney researcher should embrace
Witasp, A., Craenenbroeck, A. H. V., Shiels, P. G., Ekström, T. J., Stenvinkel, P., & Nordfors, L. (2017) · Clinical Science · doi:10.1042/cs20160596 · Cited by 13
Self-citationZhan, X., Yang, Y., Chen, Y., Wei, X., Xiao, J., Zhang, L., Yan, C., Qiu, P., Liu, S., Hu, Q.-L., et al. (2019) · Renal Failure · doi:10.1080/0886022x.2019.1646662 · Cited by 11
Lin, W., Tsai, J., Lai, Y., Lin, Y., Kuo, C., Wang, C., & Hsu, B. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1714654 · Cited by 11
Zuo, J., Chaykovska, L., Chu, C., Chen, X., Hasan, A. A., Krämer, B. K., Tepel, M., & Hocher, B. (2022) · Antioxidants · doi:10.3390/antiox11101975 · Cited by 12
‘Essential’ arterial hypertension: time for a paradigm change
Rossi, G. P., Bagordo, D., Rossi, F. B., Pintus, G., Rossitto, G., & Seccia, T. M. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003767 · Cited by 16
Transition Metals and Other Forms of Oxidative Protein Damage in Renal Disease
Monnier, V. M., Nemet, I., Sell, D. R., & Weiss, M. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_2 · Cited by 11
Wang, J., Zhou, J., Zheng, Q., Gan, H., & Wang, H. (2014) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12040 · Cited by 11
Glycated Hemoglobin Predicts Mortality in Nondiabetic Patients Receiving Chronic Peritoneal Dialysis
Chen, K., Lin, J., Lin‐Tan, D., Hsu, C., Huang, W., Yen, T., Weng, S., & Hung, C. (2010) · American Journal of Nephrology · doi:10.1159/000321899 · Cited by 11
Ohkita, M., Takaoka, M., & Matsumura, Y. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r10fm · Cited by 11
Bossola, M., & Tazza, L. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12345 · Cited by 11
Chen, J., Lin, T., Liao, S., Lee, W., Lee, L.-C., Liou, C., Wang, P., & Tiao, M. (2009) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-8-10 · Cited by 11
Salivary levels of interleukin-6 and tumor necrosis factor-α in patients undergoing hemodialysis
Alikhani, M., Khozeymeh, F., Mortazavi, M., Khalighinejad, N., & Khaleghi, M. A. (2016) · Dental Research Journal · doi:10.4103/1735-3327.174720 · Cited by 11
Apeland, T., Mansoor, M. A., Furriol, J., Ushakova, A., Jonsson, G., Stangeland, K. W., & Marti, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.05.005 · Cited by 11
Brown, A. K., Nichols, A., Coley, C. A., Ekperikpe, U. S., McPherson, K. C., Shields, C. A., Poudel, B., Cornelius, D. C., & Williams, J. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.765305 · Cited by 11
Tsai, J.-P., Yang, F., Wang, C., Fang, T., Lee, R.-P., & Hsu, B. (2010) · Tzu Chi Medical Journal · doi:10.1016/s1016-3190(10)60047-x · Cited by 11
Busch, M., Schwenzky, A., Franke, S., Stein, G., & Wolf, G. (2012) · Blood Purification · doi:10.1159/000338923 · Cited by 11
Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
Chinnappa, S., Hothi, S. S., & Tan, L. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.879040 · Cited by 11
Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis
Yang, C., Chau, Y., Chen, A., Lee, O. K., Tarng, D., & Yang, A. (2017) · World Journal of Nephrology · doi:10.5527/wjn.v6.i3.111 · Cited by 11
Maggiore, U., Cristol, J., Canaud, B., Dupuy, A., Formica, M., Pozzato, M., Panichi, V., Consani, C., Metelli, M. R., Sereni, L., et al. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.03.002 · Cited by 12
Pechter, Ü., Aunapuu, M., Riispere, Ž., Vihalemm, T., Kullisaar, T., Zilmer, K., Zilmer, M., & Ots, M. (2004) · Nephron Experimental Nephrology · doi:10.1159/000078404 · Cited by 11
Editorial: Diet, Inflammation, and Chronic Kidney Disease: Getting to the Heart of the Matter
Neade, T., & Uribarri, J. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00445.x · Cited by 11
Dyslipidemia in Chronic Kidney Disease
Streja, E., & Streja, D. A. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch34 · Cited by 11
Metadata
- Authors
- Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M.
- Affiliations
- Maine Medical Center (US)
- Corresponding author
- Himmelfarb, Jonathan
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 62
- Issue
- 5
- Pages
- 1524-1538
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1996978408
- Cited by
- 1,179
- References
- 294
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 29 · 2023: 31 · 2022: 36 · 2021: 51 · 2020: 40 · 2019: 30 · 2018: 43 · 2017: 57 · 2016: 49 · 2015: 57 · 2014: 58 · 2013: 71 · 2012: 68
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- uremia, oxidative stress, cardiovascular disease, atherosclerosis, inflammation, malnutrition, dialysis, uremic solutes, beta2-microglobulin, homocysteine, cysteine, antioxidant therapy, vascular access catheters, cardiovascular mortality
- MeSH terms
- Cardiovascular Diseases, Humans, Uremia, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review